A Case Study - NeuBase Therapeutics, Inc.

Issue JCB, Volume 26, Number 2, 2021 

Dietrich A. Stephan
CEO, Chairman and Founder NeuBase Therapeutics, Pittsburgh, PA USA

DOI:https://doi.org/10.5912/jcb995


Abstract:

NeuBase is accelerating the genetic revolution by developing a new class of precision genetic medicines which can be designed to increase, decrease, or change gene function, as appropriate, to resolve genetic defects that drive disease.

Download PDF